MyCompass in a Swedish Context - an Automated Self-help Intervention Targeting Mental Health Problems

Stress, Psychological Clinical Trial

Official title:

MyCompass in a Swedish Context - Lessons Learned From the Transfer of an Automated Self-help Intervention Targeting Mental Health Problems

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03659630
• Other study ID #: 2015/1268-31/2 + 2016/88
• Status: Completed
• Phase: N/A
• Start date: December 2015
• Est. completion date: January 2017

Study information

• Verified date: September 2021
• Source: Karolinska Institutet
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study present findings from the implementation of myCompass, a fully automated self-help intervention of Australian origin for mild to moderate anxiety and depression, in a Swedish context. The study also investigates the usage of a specially designed research platform aimed at handling informed consent and online surveys.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 837
• Est. completion date: January 2017
• Est. primary completion date: January 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Swedish resident

• Valid e-mail address

• 18 years old or older

• PHQ-9 score of 5-20

• GAD-7 score of 5-15

Exclusion Criteria:

• suicidal thoughts

Related Conditions & MeSH terms

• Anxiety State
• Dyssomnias
• Mild Depression
• Parasomnias
• Sleep Disturbance
• Stress, Psychological

Intervention

Behavioral:
• MyCompass
Self-help tools to change behaviours in various different domains including sleep deprivation, anxiety and depression.
• Comparison group
An email containing a brief text on general tips regarding mental health was sent out once a week.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Karolinska Institutet

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient Health Questionnaire-9 (PHQ-9)	Self-report measure on depressive symptoms. Nine items, each of which is scored 0 to 3, providing a 0 to 27 severity score, where a higher score indicates more severe depression. Scores of 5, 10, 15, and 20 are taken as the cut-off points for mild, moderate, moderate to severe and severe depression, respectively. For the purpose of this study, participants with a score between 5-20 were included.	2 weeks
Primary	Generalised Anxiety Disorder 7-item scale (GAD-7)	Self-report measure on anxiety symptoms. Seven items with score 0-21, a higher score indicating more severe anxiety. Cutoffs: Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. For the purpose of this study, participants with a score between 5-15 were included.	2 weeks